NCT01595646View on ClinicalTrials.gov

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 12, 2015

Study Completion Date

March 12, 2015

Conditions
Alzheimer's DiseaseMild Cognitive Impairment
Interventions
DRUG

Saline

Saline, administered intranasally twice per day for a 16 week duration

DRUG

Insulin detemir

20IU of insulin detemir, administered intranasally twice per day for a 16 week duration (total of 40IU insulin detemir per day)

DRUG

Insulin

20IU insulin, administered intranasally twice per day for a 16 week duration (total of 40IU insulin per day)

Trial Locations (2)

27157

Wake Forest Baptist Hospital, Winston-Salem

98493

VA Puget Sound Health Care System - American Lake Division, Tacoma

All Listed Sponsors
collaborator

Alzheimer's Association

OTHER

lead

Wake Forest University Health Sciences

OTHER

NCT01595646 - Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) | Biotech Hunter | Biotech Hunter